Hillebrand et al. demonstrated that daily injection of E5415A (1 mg) for up to 5 days induces NMO-like pathology, including loss of AQP4, complement activation, and immune-cell infiltration in rats, even in the absence of T-cell responses [11]. Here, AQP4 is linked to neuromyelitis optica.